Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 3;9(6):e04172.
doi: 10.1002/ccr3.4172. eCollection 2021 Jun.

Parapharyngeal tuberculoid mass: A rare complication of Bacillus Calmette-Guérin therapy for urothelial carcinoma in situ

Karolina A Plonowska-Hirschfeld  1 , Monica Fung  2 , Christine Glastonbury  1   3 , Patrick K Ha  1   4
Affiliations
Case Reports

Parapharyngeal tuberculoid mass: A rare complication of Bacillus Calmette-Guérin therapy for urothelial carcinoma in situ

Karolina A Plonowska-Hirschfeld et al. Clin Case Rep. .

Abstract

Local and systemic complications of Bacillus Calmette-Guérin therapy are important to recognize as they require prolonged antimicrobial therapy; molecular genomic testing may be key to diagnosis when culture data are inconclusive.

Keywords: Bacillus Calmette‐Guérin (BCG); case report; mycobacterial infection; parapharyngeal space mass; tuberculoid mass.

PubMed Disclaimer

Conflict of interest statement

The authors report no relevant disclosures. PKH did serve on advisory boards for Loxo/Bayer Oncology and received research/educational funding from Stryker, Synthes, and Medtronic.

Figures

FIGURE 1
FIGURE 1
(A) Axial and (B) sagittal contrast‐enhanced computed tomography demonstrating an elongated thick‐walled, irregular fluid density collection deep to the sternocleidomastoid muscle, displacing carotid vessels anteriorly. There were no associated calcifications or infiltration of adjacent tissues
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette‐Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116(2):180‐183. - PubMed
    1. Han RF, Pan JG. Can intravesical bacillus Calmette‐Guerin reduce recurrence in patients with superficial bladder cancer? A meta‐analysis of randomized trials. Urology. 2006;67(6):1216‐1223. - PubMed
    1. De Boer EC, De Jong WH, Steerenberg PA, et al. Induction of urinary interleukin‐1 (IL‐1), IL‐2, IL‐6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette‐Guerin in superficial bladder cancer. Cancer Immunol Immunother. 1992;34(5):306‐312. - PMC - PubMed
    1. Hill AR, Premkumar S, Brustein S, et al. Disseminated tuberculosis in the acquired immunodeficiency syndrome era. Am Rev Respir Dis. 1991;144(5):1164‐1170. - PubMed
    1. Lamm DL, van der Meijden PM, Morales A, et al. Incidence and treatment of complications of bacillus Calmette‐Guerin intravesical therapy in superficial bladder cancer. J Urol. 1992;147(3):596‐600. - PubMed

Publication types